gadolinium has been researched along with Chronic Kidney Diseases in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (7.89) | 29.6817 |
| 2010's | 20 (52.63) | 24.3611 |
| 2020's | 15 (39.47) | 2.80 |
| Authors | Studies |
|---|---|
| Crowley, ST; Pun, PH | 1 |
| Rodby, RA | 1 |
| Soloff, EV; Wang, CL | 1 |
| Abu-Alfa, AK | 2 |
| Diaz-Martinez, AJ; Pagan, AD; Rodriguez-Baisi, KE; Sánchez, NP; Santaliz-Ruiz Iv, LE; Villa, J | 1 |
| Lichaa, H | 1 |
| Dan, G; Fengqiong, T; He, L; Li, H; Mingcheng, H; Yuanbo, S | 1 |
| Adams, LC; Baratto, L; Daldrup-Link, HE; Jayapal, P; Morakote, W; Ramasamy, SK; Yeom, K | 1 |
| Johansen, KL; Maripuri, S | 1 |
| Davenport, MS; Gagnier, JJ; MacEachern, MP; Shankar, PR; Singer, L; Woolen, SA | 1 |
| Alfano, G; Cappelli, G; Ferrari, A; Fontana, F; Giaroni, F; Perrone, R; Solazzo, A; Torricelli, P | 1 |
| Davenport, MS; Shankar, PR | 1 |
| Leonberg-Yoo, AK; Litt, HI; Miskulin, D; Rudnick, MR; Wahba, IM | 1 |
| Bang, J; Han, SW; Jung, WY; Ko, Y; Lim, YJ; Seo, HM; Yi, JH; Yu, MY | 1 |
| Kamata, K; Kan, S; Naito, S; Okamoto, T; Takeuchi, K; Takeuchi, Y; Tazaki, H | 1 |
| Yee, J | 1 |
| Burke, LM; Ramalho, J; Ramalho, M; Semelka, RC | 1 |
| Ramalho, J; Ramalho, M | 1 |
| Huisman, TAGM; Lequin, MH; Soares, BP | 1 |
| Harmsen, WS; Kallmes, DF; Mara, KC; Misra, S; Takahashi, EA | 1 |
| Adelman, MA; Berland, TL; Cayne, NS; Maldonado, TS; Mussa, FF; Rockman, CB; Sadek, M; Veith, FJ | 1 |
| Amet, S; Choukroun, G; Clément, O; Deray, G; Frances, C; Gauvrit, JY; Grenier, N; Janus, N; Launay-Vacher, V; Laville, M; Reinhardt, G; Stengel, B; Tricotel, A | 1 |
| Abujudeh, H; Aran, S; Daftari Besheli, L; Kay, J; Shaqdan, K | 1 |
| Bernstein, EJ; Chibnik, LB; Isakova, T; Kay, J; Sullivan, ME; Wolf, M | 1 |
| Merli, GJ; Weitz, HH | 1 |
| Chue, CD; Edwards, NC; Ferro, CJ; Moody, WE; Steeds, RP; Townend, JN | 1 |
| Finn, JP; Gales, B; Hall, TR; Hanudel, M; Luhar, A; Nayak, AB; Salusky, IB; Zaritsky, J | 1 |
| Vogt, B | 1 |
| Fink, JC; Tata, AL; Wagner, LA | 1 |
| Bose, C; Hall, KA; Hiatt, KM; Karaduta, O; Megyesi, JK; Shah, SV; Swaminathan, S | 1 |
| Hedgire, SS; Le, TQ; Lev, MH; Prabhakar, AM; Raja, AS; Sonis, JD; Wang, GX; Yun, BJ | 1 |
| Kay, J | 1 |
| Brown, M; High, WA; Jackson, BP; Lanzirotti, A; Punshon, T; Ranville, JF | 1 |
| Christensen, KN; Hanley, MM; Lee, CU; Leung, N; Moyer, TP; Pittelkow, MR | 1 |
| Bernstein, EJ; Kay, J; Schmidt-Lauber, C | 1 |
| Anavekar, NS; Chong, AH; Dowling, J; Goodman, D; Norris, R | 1 |
| Buhaescu, I; Izzedine, H | 1 |
11 review(s) available for gadolinium and Chronic Kidney Diseases
| Article | Year |
|---|---|
Risk of Nephrogenic Systemic Fibrosis in Patients With Stage 4 or 5 Chronic Kidney Disease Receiving a Group II Gadolinium-Based Contrast Agent: A Systematic Review and Meta-analysis.
Topics: Contraindications, Drug; Contrast Media; Gadolinium; Glomerular Filtration Rate; Heterocyclic Compounds; Humans; Meglumine; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Practice Guidelines as Topic; Renal Insufficiency, Chronic; Risk; Severity of Illness Index; United States; United States Food and Drug Administration | 2020 |
Risk of Nephrogenic Systemic Fibrosis in Stage 4 and 5 Chronic Kidney Disease Following Group II Gadolinium-based Contrast Agent Administration: Subanalysis by Chronic Kidney Disease Stage.
Topics: Contrast Media; Gadolinium; Humans; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency, Chronic; Risk Factors | 2020 |
Risks and Options With Gadolinium-Based Contrast Agents in Patients With CKD: A Review.
Topics: Brain; Clinical Trials as Topic; Contrast Media; Gadolinium; Glomerular Filtration Rate; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency, Chronic; Risk Factors | 2021 |
Gadolinium Retention and Toxicity-An Update.
Topics: Brain; Cognitive Dysfunction; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Pain; Renal Insufficiency, Chronic; Skin Diseases | 2017 |
Gadolinium-Based Contrast Agents: Associated Adverse Reactions.
Topics: Contrast Media; Drug Hypersensitivity; Gadolinium; Humans; Renal Insufficiency, Chronic; Risk Factors | 2017 |
Safety of Contrast Material Use in Children.
Topics: Child; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency, Chronic; Tomography, X-Ray Computed | 2017 |
Current status of nephrogenic systemic fibrosis.
Topics: Acute Kidney Injury; Contrast Media; Cytokines; Epidemiologic Methods; Gadolinium; Guideline Adherence; Humans; Nephrogenic Fibrosing Dermopathy; Practice Guidelines as Topic; Renal Insufficiency, Chronic | 2014 |
Patient safety issues in CKD: core curriculum 2015.
Topics: Acute Kidney Injury; Aged; Analgesics; Anemia; Anti-Bacterial Agents; Anticoagulants; Arrhythmias, Cardiac; Bacterial Infections; Contrast Media; Diabetic Nephropathies; Drug Interactions; Gadolinium; Glomerular Filtration Rate; Hematinics; Humans; Hyperkalemia; Hypoglycemic Agents; Insulin; Iodine Compounds; Kidney; Medication Errors; Metabolic Clearance Rate; Pain Management; Patient Safety; Pharmacokinetics; Platelet Aggregation Inhibitors; Renal Insufficiency, Chronic; Renin-Angiotensin System | 2015 |
Nephrogenic systemic fibrosis: a gadolinium-associated fibrosing disorder in patients with renal dysfunction.
Topics: Contrast Media; Drug Eruptions; Gadolinium; Humans; Hyperpigmentation; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency, Chronic | 2008 |
Nephrogenic systemic fibrosis: a systemic fibrosing disease resulting from gadolinium exposure.
Topics: Contracture; Contrast Media; Diagnosis, Differential; Gadolinium; Humans; Hyperpigmentation; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency, Chronic; Risk Factors; Skin | 2012 |
Gadolinium-induced nephrotoxicity.
Topics: Acute Kidney Injury; Animals; Contrast Media; Gadolinium; Glomerular Filtration Rate; Humans; Magnetic Resonance Imaging; Mice; Renal Insufficiency, Chronic | 2008 |
2 trial(s) available for gadolinium and Chronic Kidney Diseases
| Article | Year |
|---|---|
Comparison of nephrotoxicity between two gadolinium-contrasts, gadodiamide and gadopentetate in patients with mildly diminished renal failure.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Brain; Contrast Media; Creatinine; Cystatin C; Female; Gadolinium; Gadolinium DTPA; Glomerular Filtration Rate; Humans; Kidney Function Tests; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Renal Insufficiency, Chronic; Young Adult | 2017 |
Incidence of nephrogenic systemic fibrosis in patients undergoing dialysis after contrast-enhanced magnetic resonance imaging with gadolinium-based contrast agents: the Prospective Fibrose Nephrogénique Systémique study.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Dialysis; Female; France; Gadolinium; Humans; Incidence; Magnetic Resonance Imaging; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency, Chronic; Risk Factors | 2014 |
25 other study(ies) available for gadolinium and Chronic Kidney Diseases
| Article | Year |
|---|---|
Group II GBCM Can Be Used Safely for Imaging in Stage 4/5 CKD Patients: CON.
Topics: Contrast Media; Gadolinium; Humans; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency, Chronic | 2021 |
Group II GBCM Can Be Used Safely for Imaging in Stage 4/5 CKD Patients: PRO.
Topics: Gadolinium; Humans; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency, Chronic | 2021 |
Safety of Gadolinium-Based Contrast Agents in Patients with Stage 4 and 5 Chronic Kidney Disease: a Radiologist's Perspective.
Topics: Contrast Media; Gadolinium; Humans; Nephrogenic Fibrosing Dermopathy; Radiologists; Renal Insufficiency, Chronic | 2020 |
Group II GBCM Can Be Used Safely for Imaging in Stage 4/5 CKD Patients: COMMENTARY.
Topics: Gadolinium; Humans; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency, Chronic | 2021 |
An Unusual Case of Deep Localized Scleroderma in a Patient with Chronic Kidney Disease.
Topics: Contrast Media; Disease Progression; Female; Gadolinium; Humans; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency, Chronic; Scleroderma, Localized; Skin Diseases | 2022 |
Zeroing on Gadolinium to Complement Intravascular Ultrasound in Zero-Contrast Percutaneous Coronary Interventions.
Topics: Contrast Media; Coronary Angiography; Gadolinium; Humans; Iodine Compounds; Percutaneous Coronary Intervention; Renal Insufficiency, Chronic; Treatment Outcome; Ultrasonography, Interventional | 2022 |
The diagnostic efficacy of diffusion tensor imaging generated by gadolinium-based magnetic resonance imaging for patients with chronic kidney disease.
Topics: Diffusion Magnetic Resonance Imaging; Diffusion Tensor Imaging; Fibrosis; Gadolinium; Humans; Kidney; Magnetic Resonance Imaging; Renal Insufficiency, Chronic | 2022 |
Ferumoxytol-Enhanced MRI in Children and Young Adults: State of the Art.
Topics: Child; Contrast Media; Ferrosoferric Oxide; Gadolinium; Humans; Magnetic Resonance Imaging; Renal Insufficiency, Chronic; Young Adult | 2023 |
Risk of Gadolinium-Based Contrast Agents in Chronic Kidney Disease-Is Zero Good Enough?
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency, Chronic | 2020 |
Incidence of nephrogenic systemic fibrosis after administration of gadoteric acid in patients on renal replacement treatment.
Topics: Adult; Aged; Biopsy; Contrast Media; Drug Hypersensitivity; Female; Gadolinium; Humans; Incidence; Kidney; Magnetic Resonance Imaging; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Prevalence; Renal Insufficiency, Chronic; Retrospective Studies; Risk Factors; Rotation; Skin; Transplantation, Homologous | 2020 |
Use of Gadolinium-Based Contrast Agents in Kidney Disease Patients: Time for Change.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency, Chronic | 2020 |
Late Onset Nephrogenic Systemic Fibrosis in a Patient with Stage 3 Chronic Kidney Disease: a Case Report.
Topics: Aged; Contrast Media; Dermatologic Agents; Disease Progression; Gadolinium; Glomerular Filtration Rate; Humans; Magnetic Resonance Imaging; Male; Methotrexate; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency, Chronic; Severity of Illness Index; Skin; Ultraviolet Therapy | 2020 |
Prophylactic Hemodialysis for Protection Against Gadolinium-Induced Nephrogenic Systemic Fibrosis: A Doll's House.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Practice Guidelines as Topic; Practice Patterns, Physicians'; Renal Dialysis; Renal Insufficiency, Chronic | 2017 |
Nephrotoxicity of gadolinium-based contrast in the setting of renal artery intervention: retrospective analysis with 10-year follow-up.
Topics: Acute Kidney Injury; Aged; Contrast Media; Endovascular Procedures; Female; Follow-Up Studies; Gadolinium; Humans; Male; Radiology, Interventional; Renal Artery; Renal Dialysis; Renal Insufficiency, Chronic; Retrospective Studies; Risk Factors; Stents; Survival Analysis | 2018 |
Use of preoperative magnetic resonance angiography and the Artis zeego fusion program to minimize contrast during endovascular repair of an iliac artery aneurysm.
Topics: Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Contrast Media; Embolization, Therapeutic; Endovascular Procedures; Gadolinium; Heterocyclic Compounds; Humans; Iliac Aneurysm; Image Interpretation, Computer-Assisted; Magnetic Resonance Angiography; Male; Middle Aged; Organometallic Compounds; Predictive Value of Tests; Preoperative Care; Prosthesis Design; Renal Insufficiency, Chronic; Software; Stents; Treatment Outcome; Ultrasonography, Doppler, Duplex | 2014 |
Nephrogenic systemic fibrosis is associated with hypophosphataemia: a case-control study.
Topics: Aged; Case-Control Studies; Contrast Media; Female; Fibroblast Growth Factor-23; Gadolinium; Humans; Hypophosphatemia; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency, Chronic; Risk Factors | 2014 |
Web Exclusives. The consult guys - a trip to the hardware store: is an MRI safe?
Topics: Aged; Aortic Aneurysm, Abdominal; Gadolinium; Heart Valve Prosthesis; Humans; Magnetic Resonance Imaging; Male; Metals; Pacemaker, Artificial; Patient Safety; Prosthesis Design; Referral and Consultation; Renal Insufficiency, Chronic | 2014 |
Defining the natural history of uremic cardiomyopathy in chronic kidney disease: the role of cardiovascular magnetic resonance.
Topics: Cardiomyopathies; Cardiovascular Diseases; Fibrosis; Gadolinium; Humans; Magnetic Resonance Imaging; Odds Ratio; Renal Insufficiency, Chronic; Risk Factors | 2014 |
High-resolution, whole-body vascular imaging with ferumoxytol as an alternative to gadolinium agents in a pediatric chronic kidney disease cohort.
Topics: Adolescent; Child; Child, Preschool; Contrast Media; Feasibility Studies; Female; Ferrosoferric Oxide; Gadolinium; Humans; Magnetic Resonance Angiography; Male; Renal Insufficiency, Chronic; Retrospective Studies | 2015 |
Patient safety in vascular access patients on hemodialysis: contrast agents and renal function.
Topics: Contrast Media; Creatinine; Gadolinium; Glomerular Filtration Rate; Humans; Iodine; Kidney; Magnetic Resonance Imaging; Patient Safety; Radiography; Renal Dialysis; Renal Insufficiency; Renal Insufficiency, Chronic; Vascular Access Devices | 2015 |
Evidence Suggesting a Role of Iron in a Mouse Model of Nephrogenic Systemic Fibrosis.
Topics: Animals; Contrast Media; Deferiprone; Disease Models, Animal; Gadolinium; Gadolinium DTPA; Humans; Iron; Male; Mice; Nephrogenic Fibrosing Dermopathy; Pyridones; Renal Insufficiency, Chronic | 2015 |
MR angiography can guide ED management of suspected acute aortic dissection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aortic Aneurysm, Thoracic; Aortic Dissection; Computed Tomography Angiography; Contraindications; Contrast Media; Drug Hypersensitivity; Emergency Service, Hospital; Feasibility Studies; Female; Gadolinium; Gadolinium DTPA; Humans; Iodine; Magnetic Resonance Angiography; Male; Middle Aged; Organometallic Compounds; Renal Insufficiency, Chronic; Retrospective Studies; Time Factors; Young Adult | 2017 |
Gadolinium deposition in nephrogenic systemic fibrosis: an examination of tissue using synchrotron x-ray fluorescence spectroscopy.
Topics: Aged; Aged, 80 and over; Contrast Media; Diabetic Nephropathies; Eccrine Glands; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency, Chronic; Spectrometry, Fluorescence; Synchrotrons | 2010 |
Quantification of gadolinium in fresh skin and serum samples from patients with nephrogenic systemic fibrosis.
Topics: Aged; Aged, 80 and over; Biopsy, Needle; Case-Control Studies; Contrast Media; Female; Gadolinium; Humans; Male; Mass Spectrometry; Middle Aged; Nephrogenic Fibrosing Dermopathy; Predictive Value of Tests; Radionuclide Imaging; Reference Values; Renal Insufficiency, Chronic; Sampling Studies; Sensitivity and Specificity; Severity of Illness Index; Skin; Skin Absorption | 2011 |
Nephrogenic systemic fibrosis in a gadolinium-naive renal transplant recipient.
Topics: Adult; Female; Fibrosis; Gadolinium; Humans; Immunohistochemistry; Kidney Transplantation; Leg Dermatoses; Renal Dialysis; Renal Insufficiency, Chronic; Skin | 2008 |